Brazilian Government Likely to Sanction Bill that Allows Weight Loss Drugs

06/23/2017 - 12h16

The president of Brazil, Michel Temer, is likely to put though the bill that allows the production, sale and consumption of appetite inhibitors made from amfepramone, fenproporex and mazindol.

The bill was approved by the Lower House on Tuesday, June 20, and is a reaction to the ban that Brazil's National Health Surveillance Agency (Anvisa) introduced in 2011 against these anorectics, derived from amphetamines.

At the time, Anvisa claimed that there was no proof of the drugs' effectiveness and that their risk to patients' health was bigger than their benefits.

If the bill is put through, patients will be required to present a special medical prescription (B2) to purchase medicine made from these substances.

Of the three drugs, only amfepramone is sold in the U.S., but not in Europe.

Translated by THOMAS MUELLO

Read the article in the original language

	Reprodução
	Brazil's president is likely to put though the bill that allows the production, sale and consumption of appetite inhibitors